IJzerman AP - Search Results

1

A "locked-on," constitutively active mutant of the adenosine A1 receptor.

de Ligt RA, Rivkees SA, Lorenzen A, Leurs R, IJzerman AP. de Ligt RA, et al. Among authors: ijzerman ap. Eur J Pharmacol. 2005 Mar 7;510(1-2):1-8. doi: 10.1016/j.ejphar.2005.01.007. Eur J Pharmacol. 2005. PMID: 15740718

2

2,5'-Disubstituted adenosine derivatives: evaluation of selectivity and efficacy for the adenosine A(1), A(2A), and A(3) receptor.

van Tilburg EW, von Frijtag Drabbe Kunzel J, de Groote M, IJzerman AP. van Tilburg EW, et al. Among authors: ijzerman ap. J Med Chem. 2002 Jan 17;45(2):420-9. doi: 10.1021/jm010952v. J Med Chem. 2002. PMID: 11784146

3

Apoptosis induced by extracellular ATP in the mouse neuroblastoma cell line N1E-115: studies on involvement of P2 receptors and adenosine.

Schrier SM, Florea BI, Mulder GJ, Nagelkerke JF, IJzerman AP. Schrier SM, et al. Among authors: ijzerman ap. Biochem Pharmacol. 2002 Mar 15;63(6):1119-26. doi: 10.1016/s0006-2952(01)00939-x. Biochem Pharmacol. 2002. PMID: 11931844

4

Intrinsic activity at adenosine A1 receptors: partial and inverse agonism.

de Ligt RA, IJzerman AP. de Ligt RA, et al. Among authors: ijzerman ap. Curr Pharm Des. 2002;8(26):2333-44. doi: 10.2174/1381612023392874. Curr Pharm Des. 2002. PMID: 12369948 Review.

5

Effects of the adenosine A1 receptor allosteric modulators PD 81,723 and LUF 5484 on the striatal acetylcholine release.

Bueters TJ, van Helden HP, Danhof M, IJzerman AP. Bueters TJ, et al. Among authors: ijzerman ap. Eur J Pharmacol. 2002 Nov 15;454(2-3):177-82. doi: 10.1016/s0014-2999(02)02494-9. Eur J Pharmacol. 2002. PMID: 12421644

6

2,8-Disubstituted adenosine derivatives as partial agonists for the adenosine A2A receptor.

van Tilburg EW, Gremmen M, von Frijtag Drabbe Künzel J, de Groote M, IJzerman AP. van Tilburg EW, et al. Among authors: ijzerman ap. Bioorg Med Chem. 2003 May 15;11(10):2183-92. doi: 10.1016/s0968-0896(03)00123-8. Bioorg Med Chem. 2003. PMID: 12713828

7

Synthesis and biological evaluation of disubstituted N6-cyclopentyladenine analogues: the search for a neutral antagonist with high affinity for the adenosine A1 receptor.

de Ligt RA, van der Klein PA, von Frijtag Drabbe Künzel JK, Lorenzen A, Ait El Maate F, Fujikawa S, van Westhoven R, van den Hoven T, Brussee J, IJzerman AP. de Ligt RA, et al. Among authors: ijzerman ap. Bioorg Med Chem. 2004 Jan 2;12(1):139-49. doi: 10.1016/j.bmc.2003.10.023. Bioorg Med Chem. 2004. PMID: 14697779

8

Allosteric modulation and constitutive activity of fusion proteins between the adenosine A1 receptor and different 351Cys-mutated Gi alpha-subunits.

Klaasse E, de Ligt RA, Roerink SF, Lorenzen A, Milligan G, Leurs R, IJzerman AP. Klaasse E, et al. Among authors: ijzerman ap. Eur J Pharmacol. 2004 Sep 19;499(1-2):91-8. doi: 10.1016/j.ejphar.2004.07.108. Eur J Pharmacol. 2004. PMID: 15363955

9

Allosteric modulators affect the internalization of human adenosine A1 receptors.

Klaasse EC, van den Hout G, Roerink SF, de Grip WJ, Ijzerman AP, Beukers MW. Klaasse EC, et al. Among authors: ijzerman ap. Eur J Pharmacol. 2005 Oct 17;522(1-3):1-8. doi: 10.1016/j.ejphar.2005.08.052. Epub 2005 Oct 7. Eur J Pharmacol. 2005. PMID: 16214128

10

ZM241385, DPCPX, MRS1706 are inverse agonists with different relative intrinsic efficacies on constitutively active mutants of the human adenosine A2B receptor.

Li Q, Ye K, Blad CC, den Dulk H, Brouwer J, Ijzerman AP, Beukers MW. Li Q, et al. Among authors: ijzerman ap. J Pharmacol Exp Ther. 2007 Feb;320(2):637-45. doi: 10.1124/jpet.106.111203. Epub 2006 Oct 31. J Pharmacol Exp Ther. 2007. PMID: 17077318

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

437 results

Search Page

Filters